Reig Jofre's nutritional supplements line expands its product portfolio
Forté Pharma expands its energy and health segments with the launch of eight references in the French market, as a result of its product development strategy.
Forté Pharma, Reig Jofre’s nutritional supplements line, launches in France, its home market, eight references in the energy and health segments, as a result of its strategy of development and extension of their portfolios in comparison with the weight control segment, with a higher seasonality and exposure to the evolution of consumption in Europe.
Forté Pharma has well-consolidated positioning products in the energy segment such as the Vitalité 4G line, with more than 10 years of market presence and sales leader in its category, which extends its range with Vitalité 4G Shot, concentrated spray in ginseng, guarana, ginger and royal jelly to combat temporary fatigue and lack of energy and with Vitalité 4G Senior enriched with ginkgo biloba tostrengthen brain functions, improve concentration, combat memory loss, promote cerebral blood circulation and also enriched with astragalus, known antioxidant that increases physical and mental endurance, helps to reinforce the defenses and has an anti-aging activity.
Likewise, the jelly line extends its range with Gelée Royale Dynamisant, nutritious and energetic concentrate based on royal jelly, mate, acerola and pollen, designed to strengthen the defenses and combat fatigue.
The energy segment, growing in the market for nutritional supplements in France, reaches sales of more than 170 million euros, of which Forté Pharma contributes 6 million euros, with more than 3,000 points of sale between pharmacies and parapharmacies.
In the health segment, Forté Pharma expands its line of products with five references, Forté Rub, the first nutritional supplement whose unique formula based on chronobiology, combines six natural extracts to combat common cold symptoms through a specific formula for the day to clear respiratory tract, eliminates nasal congestion, avoids coughing and restores energy; and another formula for the night that relieves throat, clears nose and fights fever to improve respiratory comfort and sleep better. Propolis Spray, highly concentrated formula for maximum effectiveness in throat care and Propolis Spray Junior, sweet formula specially adapted for children. Co-Enzyme Q10, potent antioxidant indicated in the cell protection from the harmful effects of free radicals. The range of jelly beans MiniGum for children from three years of age to help them stay in shape and improve their defenses, rest and growth, launches a new reference enriched with fiber to promote intestinal transit.
Nowadays the portfolio of Forte Pharma is organized into four segments: slimming (30% of its total sales), energy (35%), health (22%) and beauty (13%) at the end of September 2017.
Reig Jofre focused much of their efforts on enhancing the geographical diversification of Forte Pharma and expanding its product portfolio through direct support of its marketing strategy.
The positive evolution of energy and health segments in recent years made possible counteract the effect of the contraction suffered by the nutritional supplements industry for weight control in France, so the company will continue to work in this line of development.
In terms of geographic diversification, the presence of the brand in markets outside France went from 22% in 2006 to 33% at the end of 2017. At present, the marketing of Forte Pharma products is conducted mostly in Europe through own sales network. Forte Pharma’s home market, and still today the first market of the brand, is France, which concentrated 67% of sales, followed by Forte Pharma Iberica (Spain and Portugal) and Benelux, with 13% respectively, and 7% in the rest of the world.
Related News
-
News Patients vs Pharma – who will the Inflation Reduction Act affect the most?
The Inflation Reduction Act brought in by the Biden administration in 2022 aims to give better and more equitable access to healthcare in the USA. However, pharma companies are now concerned about the other potential costs of such legislation. -
News CPHI Podcast Series: What does the changing US Pharma market mean for industry and patients alike?
In this week's episode of the CPHI Podcast Series Lucy Chard, Digital Editor for CPHI Online is joined by James Manser to discuss the political and market changes in the US pharma field. -
News CPHI Barcelona Annual Report illuminates industry trends for 2024
The CPHI Annual Survey comes into it’s 7th year to report on the predicted trends for 2024. Over 250 pharma executives were asked 35 questions, with their answers informing the industry landscape for the next year, spanning all major pharma marke... -
News Which 10 drugs are open to price negotiation with Medicare in the USA?
The Centres for Medicare & Medicaid Services, under the Biden administration in the USA, has released a list of the 10 drugs that will be open to price negotiations as part of the new legislation under the Inflation Reduction Act (IRA). -
News EU Medical Devices Regulation causes unintended disappearances of medical devices for children, doctors state
Doctor groups and associations have appealed to the EU to correct the EU Medical Devices Regulation law that may cause unintended shortages of essential drug and medical devices for children and rare disease patients. -
News 10 Major Drug Approvals So Far in 2023
Last year, 37 novel drugs were approved by the FDA, this was a high number for such a category, and covered many fields including oncology, demonstrating how promising further research is, and how it is only continuing to build. To date, there are alre... -
News Detecting Alzheimer's disease with a simple lateral flow test
A novel rapid diagnostic test for early-stage Alzheimer's disease has been developed using a biomarker binder from Aptamer Group along with technology from Neuro-Bio, the neurodegenerative disease experts. -
News CPHI Podcast Series: outsourcing and manufacturing trends
Listen to the CPHI Podcast Series this June to hear Gil Roth of the PBOA speak with Digital Editor Lucy Chard about the biggest trends and topics to watch in pharma outsourcing and manufacturing at the minute.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance